Submissions

Login or Register to make a submission.

Author Guidelines

QES MedPharm Journal welcomes high-quality submissions in medicine, pharmaceutical sciences, pharmacology, toxicology, biomedical sciences, public health, and translational healthcare.

Before submitting, authors should ensure that the manuscript is original, scientifically sound, ethically conducted, clearly written, and relevant to the journal’s scope. Manuscripts that do not meet the minimum editorial, ethical, or formatting requirements may be returned or rejected before peer review.

The journal accepts original research articles, systematic reviews, meta-analyses, scoping reviews, narrative reviews, short communications, case reports, case series, perspectives, commentaries, and editorials.

Manuscripts should be written in clear English and normally include:

• A concise and informative title
• A structured or unstructured abstract appropriate to the article type
• Three to six keywords
• Clearly organized main-text sections
• Complete and accurate references
• Tables and figures cited in numerical order
• Ethical approval and informed-consent statements, where applicable
• Funding, conflict-of-interest, author-contribution, data-availability, and acknowledgements statements
• Clinical-trial registration details, where applicable
• Appropriate reporting guidelines, such as CONSORT, STROBE, PRISMA, CARE, ARRIVE, or relevant alternatives

Authors should upload a separate title page containing author names, affiliations, ORCID identifiers, corresponding-author details, acknowledgements, funding information, conflicts of interest, and author contributions.

The main manuscript should be anonymized for peer review and should not contain author names, affiliations, acknowledgements, or other identifying information.

All authors must have made a meaningful contribution to the work, approved the final manuscript, and agreed to its submission. The use of artificial intelligence or language-model tools must be disclosed when such tools were used in manuscript preparation. AI tools cannot be listed as authors.

Authors are responsible for obtaining permission to reproduce previously published material and for ensuring the accuracy of all data, references, figures, tables, and declarations.

Submission Preparation Checklist

All submissions must meet the following requirements.

  • The submission is original, has not been published previously, and is not under consideration by another journal.
  • The manuscript is relevant to the aims and scope of QES MedPharm Journal.
  • All authors have made a meaningful contribution, approved the final manuscript, and agreed to its submission.
  • A separate title page has been prepared with author names, affiliations, ORCID identifiers, corresponding-author details, funding, conflicts of interest, acknowledgements, and author contributions.
  • The main manuscript has been anonymized and does not contain author names, affiliations, acknowledgements, or other identifying information.
  • The manuscript includes an appropriate abstract, keywords, clearly organized sections, complete references, and all required declarations.
  • Ethical approval, informed consent, animal-welfare compliance, and clinical-trial registration information have been provided where applicable.
  • The manuscript follows the appropriate reporting guideline, such as CONSORT, STROBE, PRISMA, CARE, ARRIVE, or another relevant guideline.
  • All tables and figures are numbered, cited in the text, clearly labelled, and submitted in suitable file formats and resolution.
  • Permission has been obtained for any copyrighted material reproduced or adapted from another source.
  • All funding sources, conflicts of interest, data-availability information, and use of artificial intelligence tools have been fully disclosed.
  • The references have been checked for accuracy, completeness, and consistency with the journal’s reference style.
  • The authors agree to the journal’s copyright, licensing, peer-review, publication-ethics, and editorial policies.

Original Research Articles

This section publishes original, methodologically rigorous research in medical, pharmaceutical, pharmacological, toxicological, biomedical, clinical, public health, and related health sciences. Manuscripts must present original data, clearly defined objectives, appropriate study design and statistical analysis, ethical approval where applicable, and conclusions supported by the findings. Original Research Articles are subject to editorial assessment and external peer review.

Review Articles

This section publishes systematic reviews, meta-analyses, scoping reviews, umbrella reviews, and well-structured narrative reviews addressing important topics in medicine, pharmacy, pharmacology, toxicology, biomedical sciences, and healthcare. Review articles should critically evaluate the available evidence, identify important knowledge gaps, and provide balanced conclusions. Systematic reviews and meta-analyses should follow relevant reporting guidelines, such as PRISMA, where applicable. All submissions are subject to editorial assessment and external peer review.

Case Reports and Short Communications

This section publishes clinically or scientifically important case reports, case series, brief research reports, preliminary findings, methodological advances, and concise scientific communications. Case reports should present unusual, novel, or educational clinical observations and should follow the CARE reporting guidelines where applicable. Short communications must present original findings of sufficient scientific importance in a concise format. All submissions are subject to editorial assessment and external peer review.

Editorials and Perspectives

This section publishes editorials, perspectives, invited commentaries, policy viewpoints, and expert opinions on important developments in medical, pharmaceutical, biomedical, and health sciences. Contributions are normally invited or commissioned by the editorial team and are evaluated internally for relevance, clarity, originality, and scientific accuracy.

Copyright Notice

Authors retain copyright in their published work and grant QES MedPharm Journal the right of first publication.

Articles published in QES MedPharm Journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0), unless otherwise indicated. This licence permits others to share, copy, distribute, adapt, and build upon the work for any lawful purpose, provided that appropriate credit is given to the original author or authors and the source of publication.

By submitting a manuscript, the authors confirm that:

• The work is original and does not infringe the copyright or other rights of any person or organization
• Permission has been obtained for all previously published or copyrighted material included in the manuscript
• All authors have approved the submission and agreed to the journal’s copyright and licensing terms
• The journal may publish, archive, preserve, index, distribute, and promote the accepted article in electronic and other formats

The journal does not require authors to transfer ownership of copyright.

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.